Skip to content

Lifecore Biomedical, Inc. LFCR Temporary Equity Shares Authorized

Temporary Equity Shares Authorized at other companies

MMT
Miluna Acquisition MMTX
550M
Prospect Capital logo
Prospect CapitalPSEC
833.2M-1.7%
Siebert Financial logo
Siebert FinancialSIEB
100M0.0%
CAP
CapniaCAPN
3.5M-42.4%
MMT
Miluna Acquisition MMTX
6.9M
FIP
FTAI Infrastructure Inc.FIP
19.5%

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-35.4%
Enterprise value$333.06M+8.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:TemporaryEquitySharesAuthorized.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s temporary equity shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s temporary equity shares authorized?
Lifecore Biomedical, Inc. (LFCR) reported temporary equity shares authorized of 2M in Q1 2026.